W. N. Patton

940 total citations
32 papers, 675 citations indexed

About

W. N. Patton is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, W. N. Patton has authored 32 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 11 papers in Genetics and 6 papers in Pathology and Forensic Medicine. Recurrent topics in W. N. Patton's work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Immunotherapy and Immune Responses (4 papers). W. N. Patton is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Immunotherapy and Immune Responses (4 papers). W. N. Patton collaborates with scholars based in New Zealand, United Kingdom and Australia. W. N. Patton's co-authors include Stephen T. Chambers, Stephen B. Duffull, Barry D. Hock, B. A. Chapman, Judith L. McKenzie, Ruth Spearing, Derek N.J. Hart, Alexander Steinkasserer, J. Stuart and Jennifer M. Scotter and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

W. N. Patton

32 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. N. Patton New Zealand 14 166 166 159 127 111 32 675
Wako Urano Japan 16 58 0.3× 90 0.5× 99 0.6× 166 1.3× 154 1.4× 24 1.0k
S. Guidi Italy 18 247 1.5× 96 0.6× 148 0.9× 431 3.4× 118 1.1× 44 903
Nurith Strauss Israel 14 178 1.1× 132 0.8× 346 2.2× 149 1.2× 32 0.3× 21 779
José Francisco Tomás Spain 17 173 1.0× 120 0.7× 200 1.3× 455 3.6× 175 1.6× 47 944
Ulrich Junge Germany 12 83 0.5× 94 0.6× 210 1.3× 169 1.3× 31 0.3× 32 617
William E. Beschorner United States 9 170 1.0× 126 0.8× 176 1.1× 662 5.2× 42 0.4× 11 1.1k
Voigt Jj France 11 232 1.4× 48 0.3× 87 0.5× 206 1.6× 162 1.5× 35 616
Salman Naseem Adil Pakistan 16 155 0.9× 51 0.3× 203 1.3× 317 2.5× 61 0.5× 87 774
Judith A Collett New Zealand 13 119 0.7× 95 0.6× 414 2.6× 197 1.6× 74 0.7× 21 1.1k
Hans‐Gert Heuft Germany 18 241 1.5× 100 0.6× 204 1.3× 255 2.0× 17 0.2× 52 745

Countries citing papers authored by W. N. Patton

Since Specialization
Citations

This map shows the geographic impact of W. N. Patton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. N. Patton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. N. Patton more than expected).

Fields of papers citing papers by W. N. Patton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. N. Patton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. N. Patton. The network helps show where W. N. Patton may publish in the future.

Co-authorship network of co-authors of W. N. Patton

This figure shows the co-authorship network connecting the top 25 collaborators of W. N. Patton. A scholar is included among the top collaborators of W. N. Patton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. N. Patton. W. N. Patton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patton, W. N., Ian Nivison‐Smith, Peter Bardy, et al.. (2016). Graft Transit Time Has No Effect on Outcome of Unrelated Donor Hematopoietic Cell Transplants Performed in Australia and New Zealand: A Study from the Australasian Bone Marrow Transplant Recipient Registry. Biology of Blood and Marrow Transplantation. 23(1). 147–152. 4 indexed citations
2.
Patton, W. N., Robert W. Lindeman, Andrew C. Butler, et al.. (2015). An open-label, single-arm, phase 1 study to assess biomarker effects, efficacy and safety of ofatumumab in patients with refractory chronic lymphocytic leukemia. Leukemia & lymphoma. 56(10). 2819–2825. 4 indexed citations
3.
4.
Patton, W. N., et al.. (2008). A study of changes in red cell volume and haemoglobin concentration during phlebotomy induced iron deficiency and iron repletion using the Technicon H1. Clinical & Laboratory Haematology. 13(2). 153–161. 9 indexed citations
5.
Hock, Barry D., et al.. (2006). Circulating levels and clinical significance of soluble CD86 in myeloma patients. British Journal of Haematology. 133(2). 165–172. 12 indexed citations
6.
Chambers, Stephen T., Joanne M. Sanders, W. N. Patton, et al.. (2005). Reduction of exit-site infections of tunnelled intravascular catheters among neutropenic patients by sustained-release chlorhexidine dressings: results from a prospective randomized controlled trial. Journal of Hospital Infection. 61(1). 53–61. 43 indexed citations
7.
Scotter, Jennifer M., Peter B. Campbell, Trevor P. Anderson, et al.. (2005). Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis. Pathology. 37(3). 246–253. 38 indexed citations
8.
Scotter, Jennifer M., et al.. (2004). Diagnosis of aspergillus peritonitis in a renal dialysis patient by PCR and galactomannan detection: Table 1. Journal of Clinical Pathology. 57(6). 662–664. 10 indexed citations
9.
Hock, Barry D., Judith L. McKenzie, W. N. Patton, et al.. (2003). The clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndrome. Cancer. 98(8). 1681–1688. 23 indexed citations
10.
Hanley, John, et al.. (2000). Hemorrhagic lymphadenopathy as a presenting feature of primary al amyloidosis. Pathology. 32(1). 21–23. 5 indexed citations
11.
Stanworth, Simon, et al.. (1999). Automated counting of platelets on the Bayer ADVIATTMM 120 analyser. Clinical & Laboratory Haematology. 21(2). 113–118. 33 indexed citations
12.
Vučković, Slavica, et al.. (1999). Dendritic cells in chronic myelomonocytic leukaemia. British Journal of Haematology. 105(4). 974–985. 34 indexed citations
13.
14.
Hill, Geoffrey R., et al.. (1997). The use of low dose Orgaran in heparin-induced thrombocytopenia associated with in vitro platelet aggregation at higher Orgaran concentrations. Clinical & Laboratory Haematology. 19(2). 155–157. 5 indexed citations
15.
Snowden, John A., Margaret Hutchings, Ruth Spearing, & W. N. Patton. (1997). Acquired high titre factor VIII inhibitor with underlying polyarteritis nodosa. Pathology. 29(2). 221–223. 2 indexed citations
16.
Sorg, Ursula R., W. N. Patton, Barry D. Hock, et al.. (1997). Hodgkin’s cells express CD83, a dendritic cell lineage associated antigen. Pathology. 29(3). 294–299. 39 indexed citations
17.
Patton, W. N. & Stephen B. Duffull. (1994). Idiosyncratic Drug-Induced Haematological Abnormalities. Drug Safety. 11(6). 445–462. 47 indexed citations
18.
Bunce, Christopher M., Philip J. French, W. N. Patton, et al.. (1992). Levels of inositol metabolites within normal myeloid blast cells and changes during their differentiation towards monocytes. Proceedings of the Royal Society B Biological Sciences. 247(1318). 27–33. 11 indexed citations
19.
Bunce, Christopher M., W. N. Patton, John D. Pound, Janet M. Lord, & G. E. Brown. (1990). Phorbol myristate acetate treatment of normal human myeloid blast cells promotes monopoiesis and inhibits granulopoiesis. Leukemia Research. 14(11-12). 1007–1017. 7 indexed citations
20.
Sangster, Graeme, et al.. (1989). Treatment of refractory and relapsed non-Hodgkin's lymphoma with ifosfamide, methotrexate and etoposide. Cancer Chemotherapy and Pharmacology. 23(4). 263–265. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wako Urano Breakdown of academic impact, for papers by S. Guidi Breakdown of academic impact, for papers by Nurith Strauss Breakdown of academic impact, for papers by José Francisco Tomás Breakdown of academic impact, for papers by Ulrich Junge Breakdown of academic impact, for papers by William E. Beschorner Breakdown of academic impact, for papers by Voigt Jj Breakdown of academic impact, for papers by Salman Naseem Adil Breakdown of academic impact, for papers by Judith A Collett Breakdown of academic impact, for papers by Hans‐Gert Heuft
Rankless by CCL
2026